{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:50:11Z","timestamp":1649206211872},"reference-count":46,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2222\/jsv.60.49","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T11:06:35Z","timestamp":1297767995000},"page":"49-58","source":"Crossref","is-referenced-by-count":1,"title":["The lost decade of Global Polio Eradication and moving forward"],"prefix":"10.2222","volume":"60","author":[{"given":"Hiroyuki","family":"SHIMIZU","sequence":"first","affiliation":[{"name":"Department of Virology II National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","unstructured":"2) Progress toward interruption of wild poliovirus transmission--worldwide, 2008. <I>MMWR Morb Mortal Wkly Rep<\/I> 58: 308-312, 2009."},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL Aylward RB. New strategies for the elimination of polio from India. Science 314: 1150-1153, 2006.","DOI":"10.1126\/science.1130388"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, Heymann DL, Aylward RB. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 369: 1356-1362, 2007.","DOI":"10.1016\/S0140-6736(07)60531-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, Aylward RB. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 200: 794-801, 2009.","DOI":"10.1086\/605330"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Arora NK, Chaturvedi S, Dasgupta R. Global lessons from India's poliomyelitis elimination campaign. Bull World Health Organ 88: 232-234, 2010.","DOI":"10.2471\/BLT.09.072058"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Paul Y. Why polio has not been eradicated in India despite many remedial interventions? Vaccine 27: 3700-3703, 2009.","DOI":"10.1016\/j.vaccine.2009.03.078"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Paul Y. Polio eradication in India: have we reached the dead end? Vaccine 28: 1661-1662, 2010.","DOI":"10.1016\/j.vaccine.2009.11.084"},{"key":"8","unstructured":"9) Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009. MMWR Morb Mortal Wkly Rep 58: 1150-1154, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Abanida EA, Koleosho-Adelekan T, Grassly NC. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med 359: 1666-1674, 2008.","DOI":"10.1056\/NEJMoa0803259"},{"key":"10","unstructured":"11) Progress toward poliomyelitis eradication - Afghanistan and Pakistan, 2009. MMWR Morb Mortal Wkly Rep 59: 268-272, 2010."},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Mushtaq MU, Majrooh MA, Ullah MZ, Akram J, Siddiqui AM, Shad MA, Waqas M, Abdullah HM, Ahmad W, Shahid U, Khurshid U. Are we doing enough? Evaluation of the Polio Eradication Initiative in a district of Pakistan's Punjab province: a LQAS study. BMC Public Health 10: 60, 2010.","DOI":"10.1186\/1471-2458-10-60"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296: 356-359, 2002.","DOI":"10.1126\/science.1068284"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, Utama A, Tano Y, Arita M, Yoshida H, Yoneyama T, Benegas A, Roesel S, Pallansch M, Kew O, Miyamura T. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78: 13512-13521, 2004.","DOI":"10.1128\/JVI.78.24.13512-13521.2004"},{"key":"14","unstructured":"15) Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82: 16-23, 2004."},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587-635, 2005.","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Wringe A, Fine PE, Sutter RW, Kew OM. Estimating the extent of vaccine-derived poliovirus infection. PLoS One 3: e3433, 2008.","DOI":"10.1371\/journal.pone.0003433"},{"key":"17","unstructured":"18) Vaccine-derived polioviruses detected worldwide, January 2008-June 2009. Wkly Epidemiol Rec 84: 390-396, 2009."},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Arita M, Zhu SL, Yoshida H, Yoneyama T, Miyamura T, Shimizu H. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79: 12650-12657, 2005.","DOI":"10.1128\/JVI.79.20.12650-12657.2005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Jiang P, Faase JA, Toyoda H, Paul A, Wimmer E, Gorbalenya AE. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A 104: 9457-9462, 2007.","DOI":"10.1073\/pnas.0700451104"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, Riquet F, Martin J, Kew O, Randriamanalina B, Razafinimpiasa L, Rousset D, Delpeyroux F. Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar. PLoS Pathog 3: e191, 2007.","DOI":"10.1371\/journal.ppat.0030191"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23) Jegouic S, Joffret ML, Blanchard C, Riquet FB, Perret C, Pelletier I, Colbere-Garapin F, Rakoto-Andrianarivelo M, Delpeyroux F. Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog 5: e1000412, 2009.","DOI":"10.1371\/journal.ppat.1000412"},{"key":"22","doi-asserted-by":"crossref","unstructured":"24) Hagiwara A, Yoneyama T, Yoshii K, Yoshida H, Shimizu H, Wada J, Thanh NT, Van Tu P, Miyamura T: Genetic analysis of wild polioviruses towards the eradication of poliomyelitis from the Western Pacific Region. Jpn J Infect Dis 52: 146-149, 1999.","DOI":"10.7883\/yoken.52.146"},{"key":"23","doi-asserted-by":"crossref","unstructured":"25) Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, Jegathesan M, Anderson LJ. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31: 678-683, 2000.","DOI":"10.1086\/314032"},{"key":"24","doi-asserted-by":"crossref","unstructured":"26) Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341: 929-935, 1999.","DOI":"10.1056\/NEJM199909233411301"},{"key":"25","doi-asserted-by":"crossref","unstructured":"27) Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, Sinniah M, Yusof MA, Okuno Y, Okabe N, Shih SR, Chen HY, Wang GR, Kao CL, Chang KS, Miyamura T, Hagiwara A. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis 52: 12-15, 1999.","DOI":"10.7883\/yoken.52.12"},{"key":"26","doi-asserted-by":"crossref","unstructured":"28) McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91-107, 2002.","DOI":"10.1111\/j.1574-6976.2002.tb00601.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"29) Bible JM, Pantelidis P, Chan PK, Tong CY. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol 2007.","DOI":"10.1002\/rmv.538"},{"key":"28","doi-asserted-by":"crossref","unstructured":"30) Qiu J: Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7: 868-869, 2008.","DOI":"10.1016\/S1474-4422(08)70207-2"},{"key":"29","unstructured":"31) Fan Y, Lili R, Zhaohui X, Jianguo L, Yan X, Rong Z, Yaqing H, Ge B, Shili Z, Jianwei W, Jin Q. Enterovirus 71 Outbreak in P. R. China, 2008. J Clin Microbiol 2009."},{"key":"30","doi-asserted-by":"crossref","unstructured":"32) Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 44: 262-267, 2009.","DOI":"10.1016\/j.jcv.2009.02.002"},{"key":"31","unstructured":"33) Ministry of Health P.R China (http:\/\/www.moh.gov.cn\/publicfiles\/\/business\/htmlfiles\/wsb\/index.htm)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"35) Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T: Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 46: 231-235, 2004.","DOI":"10.1046\/j.1442-200x.2004.01868.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"36) Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Miyamura T, Sata T, Iwasaki T: Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 67: 207-216, 2002.","DOI":"10.1002\/jmv.2209"},{"key":"34","doi-asserted-by":"crossref","unstructured":"37) Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Hasegawa H, Sata T, Miyamura T, Shimizu H: Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol 85: 2981-2989, 2004.","DOI":"10.1099\/vir.0.79883-0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"38) Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T: Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86: 1391-1401, 2005.","DOI":"10.1099\/vir.0.80784-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"39) Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H: An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 81: 9386-9395, 2007.","DOI":"10.1128\/JVI.02856-06"},{"key":"37","doi-asserted-by":"crossref","unstructured":"40) Arita M, Ami Y, Wakita T, Shimizu H: Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD\/SCID mouse infection model. J Virol 82: 1787-1797, 2008.","DOI":"10.1128\/JVI.01798-07"},{"key":"38","doi-asserted-by":"crossref","unstructured":"41) Arita M, Wakita T, Shimizu H: Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J Gen Virol 89: 2518-2530, 2008.","DOI":"10.1099\/vir.0.2008\/002915-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"42) Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15: 794-797, 2009.","DOI":"10.1038\/nm.1961"},{"key":"40","doi-asserted-by":"crossref","unstructured":"44) Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, Aylward BR. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis 201: 1535-1543, 2010.","DOI":"10.1086\/651952"},{"key":"41","unstructured":"45) WHO Regional Office of Europe: Polio situation update from Tajikistan (http:\/\/www.euro.who.int\/ communicablediseases\/outbreaks\/20100429_1)"},{"key":"42","doi-asserted-by":"crossref","unstructured":"46) Arita I, Nakane M, Fenner F. Public health. Is polio eradication realistic? Science 312: 852-854, 2006.","DOI":"10.1126\/science.1124959"},{"key":"43","doi-asserted-by":"crossref","unstructured":"47) Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, Aylward RB. New strategies for the elimination of polio from India. Science 314: 1150-1153, 2006.","DOI":"10.1126\/science.1130388"},{"key":"44","doi-asserted-by":"crossref","unstructured":"48) Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet 369: 1363-1371, 2007.","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"49) Emerson CI, Singer PA. Is there an ethical obligation to complete polio eradication? Lancet 375: 1340-1341, 2010.","DOI":"10.1016\/S0140-6736(10)60565-X"},{"key":"46","unstructured":"50) Mohamed AJ, Ndumbe P, Hall A, Tangcharoensathien V, Toole MJ, Wright P. Independent evaluation of major barriers to interrupting poliovirus transmission. EXECUTIVE SUMMARY, 2009. (http:\/\/www.polioeradication.org\/content\/general\/Polio_Evaluation_CON.pdf)"}],"container-title":["Uirusu"],"original-title":["\u4e16\u754c\u30dd\u30ea\u30aa\u6839\u7d76\u306e\u5931\u308f\u308c\u305f10\u5e74\u3068\u30dd\u30ea\u30aa\u6839\u7d76\u8a08\u753b\u306e\u3053\u308c\u304b\u3089"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/60\/1\/60_1_49\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:17:00Z","timestamp":1637281020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/60\/1\/60_1_49\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.60.49","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}